Reflects Changes in Pharmacy Coverage Required by Section 175 of the Medicare Improvement for Patients and Providers Act of 2008 to Include Barbiturates "Used in the Treatment of Epilepsy, Cancer, or Chronic Mental Health Disorder" and Benzodiazepines in Part D Drug Coverage.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media